Women with pregnancy-related diabetes may be at risk for chronic kidney disease

Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears in Diabetes Care. Gestational diabetes occurs only in pregnancy and results when the level of blood sugar is too high. The condition increases the risk for preterm […]

Continue reading »

Many Americans say infectious and emerging diseases in other countries will threaten the US

An overwhelming majority of Americans (95%) think infectious and emerging diseases facing other countries will pose a ‘major’ or ‘minor’ threat to the U.S. in the next few years, but more than half (61%) say they are confident the federal government can prevent a major infectious disease outbreak in the U.S., according to a new national public opinion survey commissioned […]

Continue reading »

Rare plant compounds could hold key to treating resistant hypertension

Researchers have discovered new natural compounds in a fig plant species native to Malaysia that could lead to improved treatment for resistant hypertension. Dr. Kuan Hon Lim and his team from the University of Nottingham Malaysia have isolated a new class of natural compounds from a local fig plant species that induce vasodilation in aorta tissue, meaning the compounds have […]

Continue reading »

British baby names you’ll fall in love with

When you think of a grand, iconic British name, what moniker comes to mind? Victoria — of course. Elizabeth, perhaps? Agatha? Nigel? Edwin? Percival? Quintessentially English names will never go out of style, but since we’re also talking about Wales, Scotland, and the Irish Republic here, British monikers have an infinite appeal that’s as grounded in mythology and folklore as […]

Continue reading »

Experimental MERS treatments enter clinical trial

Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat people infected with Middle East respiratory syndrome coronavirus (MERS-CoV). The trial is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and is funded in part by the Biomedical Advanced Research […]

Continue reading »
1 225 226 227 228 229 270